Strategic Analysis of Threats for AstraZeneca

This document is a strategic analysis report focusing on the evolving threat landscape faced by AstraZeneca. It outlines the company's extensive global clinical trial network and the associated risks of data breaches, particularly concerning sensitive genomic data and protected health information. The report highlights significant security challenges, including the rise in voice phishing attacks and the need for a cohesive security strategy amidst rapid digital transformation in the pharmaceutical sector. It presents a practical 120-day roadmap for implementing Zero Trust research environments, emphasizing the importance of protecting intellectual property and maintaining operational resilience. The analysis details critical threat vectors, such as cloud-conscious attacks and identity-based threats, and discusses the necessity for a unified security architecture to enhance threat detection and response capabilities. The report concludes with a structured framework for building robust security measures tailored to AstraZeneca's unique operational needs, ensuring compliance with regulatory requirements while fostering collaborative innovation.